Interviews with the world’s key opinion leaders in cancer

TagDCIS

Jelle Wesseling MD PhD; 2026 EBCC: ‘Lord’ Trial Finds Active Surveillance for Estrogen-Receptor-Positive, HER2- Negative, Grade 1–2 DCIS Just As Effective as Standard Therapy

2 months ago

Audio Journal of Oncology Podcast Jelle Wesseling MD PhD; 2026 EBCC: ‘Lord’ Trial Finds Active Surveillance for Estrogen-Receptor-Positive, HER2...

April 17, 2018

Audio Journal of Oncology Podcast Reassurance on Ductal Carcinoma in Situ (DCIS) Treatment De-Escalation Play Episode Pause Episode Mute/Unmute...